Sequence Analysis & Mutation Detection Solutions

Infectious Disease Reporting & Mutation Detection

Analysis Solutions

From its origins in HIV drug-resistance testing, Hyrax has extended the Exatype genotyping platform to accommodate any disease or test.


Consolidated HIV Genotyping solution for sequencing done by capillary electrophoresis (CE), e.g. the Applied Biosystems 3730 and 3500 Series Genetic Analyzers.

Download PDF


Our proviral solution assists in the selection of drug regimens that are better-tolerated in treatment-experienced people.

Download PDF


Targeted and whole genome NGS solutions for antibiotic resistance reporting and lineage typing in Mycobacterium tuberculosis.

Download PDF

Get Started with a Free Trial View Pricing

The Exatype Platform: An end-to-end Bioinformatics Software Platform

Our modular platform can analyse and interpret sequence data from an ever-expanding range of applications, including:

Genotyping and drug-resistance testing in infectious diseases e.g. HIV, Mtb, SARS-CoV-2.

Multi-target diagnostics, e.g. infectious disease panels.

Tumour profiling and drug-susceptibility testing in cancer.

Low abundance variant detection e.g. detecting mixed infections or the detection of biomarkers in liquid biopsies.

View our Platform Solutions

A look inside our Exatype NGS analysis software

Your Sequence data.

One Solution.

Discover our sequence-analysis solutions